...
首页> 外文期刊>Bioresource Technology: Biomass, Bioenergy, Biowastes, Conversion Technologies, Biotransformations, Production Technologies >Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus
【24h】

Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus

机译:从平菇子实体分离的新型多糖的结构表征和体外抗肿瘤活性

获取原文
获取原文并翻译 | 示例

摘要

A novel water-soluble polysaccharide(POPS-1)was obtained from the fruiting bodies of Pleurotus ostreatus by hot water extraction,ethanol precipitation,and fractionated by DEAE-cellulose ion exchange chromatography and sepharose CL-6B gel filtration chromatography using an ATKA explore 100 purifier.The structure characterization and antitumor activity of the POPS-I were evaluated in this paper. According to GC analysis, HPGPC,FT-IR,partial acid hydrolysis, periodate oxidation and Smith degradation,methylation and GC-MS analysis,the results indicate POPS-1(M-w=31 kDa)was composed of Man; Gal;Glc with a molar ratio of 1:2.1:7.9, it had a backbone of beta-(1 ->3)-linked glucose residues,which occasionally branches at O-6. The branches were composed of(1->3)-linked Glc,(1->4)-linked Gal,(1->4)-linked Man, and terminated with Glc and Gal residues. Cytotoxicity assay showed POPS-1 presented significantly higher antitumor activity against Hela tumor cell in vitro,in a dose-dependent manner,and exhibited significantly lower cytotoxicity,to human embryo kidney 293T cells than Hela tumor cells compared with 5-Fu.The results suggest POPS-1 may be considered as a potential candidate for developing a novel low toxicity antitumor agent.
机译:通过热水提取,乙醇沉淀从平菇子实体中获得了一种新型水溶性多糖(POPS-1),并用ATKA Explore 100通过DEAE-纤维素离子交换色谱法和琼脂糖凝胶CL-6B凝胶过滤色谱法进行了分离。本文对POPS-I的结构表征和抗肿瘤活性进行了评估。根据GC分析,HPGPC,FT-IR,部分酸水解,高碘酸盐氧化和Smith降解,甲基化和GC-MS分析,结果表明POPS-1(M-w = 31 kDa)由Man组成; Gal; Glc的摩尔比为1:2.1:7.9,它具有一个由β-(1-> 3)连接的葡萄糖残基的主链,偶尔在O-6处分支。分支由(1-> 3)-连接的Glc,(1-> 4)-连接的Gal,(1-> 4)-连接的Man组成,并由Glc和Gal残基终止。细胞毒性试验显示,与5-Fu相比,POPS-1对人胚肾293T细胞的体外抗Hela肿瘤细胞活性显着提高,呈剂量依赖性,对人胚胎肾293T细胞的毒性明显降低。 POPS-1可以被认为是开发新型低毒性抗肿瘤剂的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号